- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05643222
Performance of Red Tinted Contact Lenses on Colour Defects (CL)
December 1, 2022 updated by: National University of Malaysia
The Performance of Red Tinted Contact Lenses of Various Tones on Colour Deficient Subjects: A Pilot Study
This study aimed to relate and compare the performance of 4 types of red-tinted contact lenses (CL) with the Total Error Score (TES) from the Farnsworth-Munsell 100 Hue test on colour deficient subjects.
Only 6 subject with colour vision defect was tested in this study.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Six congenital CVD subjects were recruited.
After colour vision screening using Ishihara plate, the Farnsworth-Munsell 100 Hue test was carried out to determine the type and severity of colour vision deficiency.
Four types of red-tinted CL (Type A, B, C and D) were used.
The performance of each of these lenses was determined through the comparison of error scores in the Ishihara test before and after wearing tinted contact lens on only the non-dominant eye.
Then, the transmittance of each tinted CL was determined using a spectrophotometer.
All these lenses were fitted on the subjects in one day where the subjects were given a 30-minute break for each intervention.
Study Type
Interventional
Enrollment (Actual)
6
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kuala Lumpur, Malaysia, 50300
- Optometry Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age range 18-40 years
- all sex
- color defect diagnosed with Ishihara Test
- no contraindication in contact lens wear
Exclusion Criteria:
- have ocular and systemic diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: TES and performance assessment with Type A Red Tint Lens
6 subjects will be inserted with the Type A red Tint Lenses.
Only the non dominant eye will be inserted.
The comparison is made before and after wearing the CL.
|
to compare the performance of these lenses.
Other Names:
|
|
Active Comparator: TES and performance assessment with Type B Red Tint Lens
6 subjects will be inserted with the Type B red Tint Lenses.
Only the non dominant eye will be inserted.
The comparison is made before and after wearing the CL.
|
to compare the performance of these lenses.
Other Names:
|
|
Active Comparator: TES and performance assessment with Type C Red Tint Lens
6 subjects will be inserted with the Type C red Tint Lenses.
Only the non dominant eye will be inserted.
The comparison is made before and after wearing the CL.
|
to compare the performance of these lenses.
Other Names:
|
|
Active Comparator: TES and performance assessment with Type D Red Tint Lens
6 subjects will be inserted with the Type D red Tint Lenses.
Only the non dominant eye will be inserted.
The comparison is made before and after wearing the CL.
|
to compare the performance of these lenses.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The lens which gives the best result in TES value
Time Frame: 30 minutes after lens adaptation. Lens is removed immediately after the assessment is completed.
|
The highest TES value scored showed higher performance in colour vision.
TES is an automated, generated value that calculates the number of tiles placed incorrectly and scales the value for uniform analysis.
Average TES scores range from thirty to forty in series tests; while scores exceeding seventy can point to a marker for color blindness.
Lower scores are intended to point to significantly increased color vision accuracy, as the TES score is directly correlated to the number of tiles incorrectly identified
|
30 minutes after lens adaptation. Lens is removed immediately after the assessment is completed.
|
|
The lens which gives the best performance in ES value
Time Frame: 30 minutes after lens adaptation. Lens is removed immediately after the assessment is completed
|
The highest score achieved using Ishihara Test indicates the best red tint lens.
The current passing score is 12 correct of 14 red/green test plates (not including the demonstration plate).
Research has shown that scores below twelve indicate color vision deficiency, and twelve or more correct indicate normal color vision, with 97% sensitivity and 100% specificity
|
30 minutes after lens adaptation. Lens is removed immediately after the assessment is completed
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Haliza Abdul Mutalib, PhD, UKM
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 20, 2020
Primary Completion (Actual)
April 30, 2021
Study Completion (Actual)
July 31, 2021
Study Registration Dates
First Submitted
November 21, 2022
First Submitted That Met QC Criteria
December 1, 2022
First Posted (Estimate)
December 8, 2022
Study Record Updates
Last Update Posted (Estimate)
December 8, 2022
Last Update Submitted That Met QC Criteria
December 1, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UKM PPI/111/8/JEP-2021-145
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
only the executive summary of all data analysis published by journals will be made available.
IPD will be shared only when requested.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Color Vision Defects
-
University of the Incarnate WordNational Eye Institute (NEI)CompletedColor Vision Defects | Color Blindness | Color Blindness, Red | Color Blindness, GreenUnited States
-
University of Colorado, DenverCompletedColor Blindness, AcquiredUnited States
-
Skolkovo Institute of Science and TechnologyI.M. Sechenov First Moscow State Medical UniversityRecruitingHealthy Volunteer | Visual Snow Syndrome | Color BlindnessRussian Federation
-
Aalen UniversityKarlsruhe Institute of Technology (KIT), Karlsruhe/FRGCompletedReaction Time | Color Blindness, RedGermany
-
B.P. Koirala Institute of Health SciencesCompleted
-
Yanyun ZhangCompletedVisual Impairment and Blindness (Excl Colour Blindness)China
-
National University of Science and TechnologyActive, not recruitingAnxiety Disorder of AdolescencePakistan
-
Dot Glasses KenyaQueen's University, Belfast; University of Stellenbosch; Sun King; Livelihood Impact...Not yet recruitingPresbyopia Correction | Livelihoods | Visual Impairment and Blindness (Excl Colour Blindness) | Repayment Behaviour
-
Medipol UniversityCompletedCAD Test; Children's Vision; Colour Assessment; Colour Vision; TurkeyTurkey
-
Soul Medicine InstituteRecruiting
Clinical Trials on red tint contact lenses
-
University of WashingtonSeattle Children's HospitalWithdrawnMyopiaUnited States
-
Aller, Thomas A., ODJohnson & Johnson Vision Care, Inc.CompletedMyopia | Esophoria | Fixation Disparity
-
Aston UniversityCooperVision, Inc.Enrolling by invitationContact Lens Wear | Healthy Participants Study | Contact Lens FitUnited Kingdom
-
University of Alabama at BirminghamRecruitingConcussion, Mild | Photophobia | Contact LensUnited States
-
Ohio State UniversityRecruitingPresbyopia | Presbyopia CorrectionUnited States
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
-
Ohio State UniversityUniversity of HoustonCompleted
-
Aston UniversityCollege of OptometristsCompletedHyperopia | Amblyopia | AnisohyperopiaUnited Kingdom
-
Visioneering Technologies, IncActive, not recruitingMyopiaCanada, United States, Hong Kong, Singapore
-
CooperVision, Inc.Completed